Two pharma giants are combining forces to take on multiple cancers in a deal worth up to $8.5 billion.
AstraZeneca’s combination of two injectable immunotherapy drugs failed to help patients as hoped in a closely watched advanced lung cancer trial, triggering the biggest ever daily fall in its shares.
Cochlear Ltd. said it can now stream audio directly from Apple Inc.’s iPhone, iPad and iPod to the microchips in its hearing implants without having to use an additional device.
HIV-positive patients may soon have a new treatment option that can be taken without food restrictions and has a much lower rate of drug interference with other medications patients may be taking.
A preliminary advisory committee report by the FDA once again pointed to some serious safety issues with Dynavax Technologies’ troubled hepatitis B treatment Heplisav-B.
GSK’s new chief executive announced plans to narrow the focus of the group’s drug research by ditching 30-plus projects to improve returns in its core pharma business.
Anthem Inc. said it may exit more individual Obamacare markets as the future of the national healthcare law and the government subsidies that make insurance affordable for millions of Americans remain up in the air.
After a months-long struggle, Republicans have succeeded in bringing Obamacare repeal legislation – a centerpiece of their 2016 election campaigns – to a debate on the U.S. Senate floor.
FDA’s commissioner told staff in an email that he intends to delay any labor reductions until the end of September unless Congress authorizes its user fee program to provide the necessary funding.
Razorfish Health Announces the Promotion of Keri Hettel to SVP, Analytics and Strategy and Brandon Ashcraft to SVP, Operations
Razorfish Health, a uniquely integrated health and wellness advertising agency, announced the promotion of Keri Hettel to SVP, Analytics and Strategy, and Brandon Ashcraft to SVP, Operations.